{"url":"https://lda.senate.gov/api/v1/filings/c4eec8a0-ae43-4050-b5fe-0a1fa3f482eb/","filing_uuid":"c4eec8a0-ae43-4050-b5fe-0a1fa3f482eb","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2008,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/c4eec8a0-ae43-4050-b5fe-0a1fa3f482eb/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Steven McCain, Government Affairs Advisor","dt_posted":"2008-07-21T12:05:32-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1601 K STREET, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":32098,"url":"https://lda.senate.gov/api/v1/registrants/32098/","house_registrant_id":31355,"name":"K&L GATES, LLP","description":"Law firm","address_1":"1601 K Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DINA KERLEY","contact_telephone":"+1 202-661-3767","dt_updated":"2026-07-29T12:32:27.232424-04:00"},"client":{"id":139987,"url":"https://lda.senate.gov/api/v1/clients/139987/","client_id":1002917,"name":"INTRANASAL THERAPEUTICS INC","general_description":"Specialty pharmaceutical co. developing nasally delivered pharmaceutical product","client_government_entity":false,"client_self_select":false,"state":null,"state_display":null,"country":"","country_display":"* Undetermined","ppb_state":null,"ppb_state_display":null,"ppb_country":"","ppb_country_display":"* Undetermined","effective_date":"2007-07-31"},"lobbying_activities":[{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"HR 3222, DOD Appropriations for FY08, seek appropriations and explore federal business development opportunities for medical device and pharmaceutical therapeutics.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51181,"prefix":null,"prefix_display":null,"first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MCCAIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"HR 3222, DOD Appropriations for FY08, seek appropriations and explore federal business development opportunities for medical device and pharmaceutical therapeutics.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51181,"prefix":null,"prefix_display":null,"first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MCCAIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}